As we preliminary demonstrated that CDCA3 might be related to distant metastasis of bladder urothelial carcinoma (Fig. 1d), two migration ability assays were performed to test whether it affected promoting tumor cell migration. This evidence concerns the gene CDCA3 and bladder transitional cell carcinoma.